Pharmaceutical-grade cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning issued a business update. “Over the past two quarters, we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness, and made significant commercial advancements,” Barry Fishman, CEO of ABcann, stated in the news release. “ABcann is well-positioned, with approximately $130 million in cash, to accelerate the growth of our business.” Per the update, the company’s management team has formulated a growth strategy for 2018 that is focused on several key areas, including expansion of its production capacity, a go-to-market strategy that centers on rebranding the company and introducing new consumer brands, international expansion initiatives in both Australia and Europe, a coordinated R&D program and heightened organizational effectiveness through the strengthening of its leadership team.
To view the full press release, visit http://cnw.fm/OevH5
About ABcann Global Corp.
ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. The company is expanding its cultivation capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit www.ABcannGlobal.com
More from CannabisNewsBreaks
About CanadianCannabisWire
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.canadiancannabiswire.com
Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CanadianCannabisWire (CNW)
Toronto, Ontario
www.canadiancannabiswire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com
